Mesoblast

MESO

全部股東

股東類型

  • 公眾及其他37.86%
  • 個人與內幕人士34.17%
  • 機構投資者26.10%
  • 私人企業1.08%
  • 上市公司0.79%

主要股東

主要股東 最新
股東
Gregory GeorgeNon-Independent Non-Executive Director
20.95%2.72 億0.03%+018/09/2026
Silviu ItescuFounder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
6.23%8,084.43 萬0.14%+188.53 萬18/09/2026
State Street Investment Management
5.16%6,699.53 萬<0.01%-1.83 萬23/10/2026
William Gueck
4.80%6,237.98 萬<0.01%+018/09/2026
JPMorgan Chase & Co.
4.65%6,043.28 萬0.65%-836.79 萬17/07/2026
M&G Investment Management Limited
2.73%3,545.22 萬<0.01%+030/09/2026
Vanguard Capital Management, LLC
2.47%3,212.85 萬0.01%-11.86 萬30/09/2026
BlackRock, Inc.
1.86%2,413.66 萬<0.01%-5.50 萬30/10/2026
Vanguard Investments Australia Limited
1.57%2,040.00 萬0.02%-20.08 萬30/09/2026
Dimensional Fund Advisors LP
1.36%1,761.85 萬0.02%-27.02 萬30/10/2026
Thorney Investment Group Australia Pty. Ltd.
1.08%1,398.12 萬0.01%-13.52 萬18/09/2026
AustralianSuper Advice Pty Ltd
0.88%1,147.19 萬<0.01%+030/06/2026
Norges Bank Investment Management
0.85%1,106.44 萬0.08%-100.70 萬30/06/2026
Smith & Nephew plc
0.79%1,022.82 萬<0.01%+018/09/2026
Josaka Investments Pty Ltd.
0.68%882.11 萬<0.01%+018/09/2026
James George
0.62%800.00 萬<0.01%+018/09/2026
Morgan Stanley
0.55%715.15 萬0.16%+204.02 萬30/06/2026
BetaShares Capital Limited
0.53%693.06 萬<0.01%+6.04 萬30/10/2026
Eric RoseChief Medical Officer & Executive Director
0.52%674.93 萬0.05%-64.32 萬27/08/2026
Grant George
0.46%600.00 萬<0.01%+018/09/2026